Figure 1From: Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureusTime kill experiments evaluating the bactericidal activity of vancomycin versus agr functional HA-MRSA 7 (A,E), agr dysfunctional HA-MRSA 9 (B,F), agr functional CA-MRSA 26 (C,G), and agr dysfunctional CA-MRSA 20 (D,H) at low and high initial inoculum (106, 108 log 10 cfu/ml).Back to article page